Leisure Capital Management’s Gilead Sciences GILD Stock Holding History

Leisure Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,385	Closed	-$1.34M	–	133
2023 Q2	$1.34M	Buy	17,385 +53	+0.3%	+$4.23K	0.74%	42
2023 Q1	$1.44M	Buy	17,332 +14,425	+496%	+$1.19M	0.82%	40
2022 Q4	$250K	Buy	+2,907	New	+$230K	0.13%	127
2022 Q1	–	Sell	-2,901	Closed	-$211K	–	139
2021 Q4	$211K	Buy	+2,901	New	+$200K	0.1%	146
2021 Q2	–	Sell	-3,249	Closed	-$210K	–	151
2021 Q1	$210K	Sell	3,249 -500	-13%	-$32.2K	0.13%	134
2020 Q4	$218K	Buy	+3,749	New	+$226K	0.14%	126
2020 Q3	–	Sell	-2,749	Closed	-$212K	–	120
2020 Q2	$212K	Hold	2,749	–	–	0.17%	114
2020 Q1	$206K	Buy	+2,749	New	+$190K	0.2%	114

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Leisure Capital Management's GILD Position: Q3 2023 in Review

Leisure Capital Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 17,385 shares — an estimated $1.34M sold.

Leisure Capital Management first reported a position in GILD in Q1 2020 and held it in 8 quarters. The position peaked at $1.44M in Q1 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Leisure Capital Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Leisure Capital Management sold 17,385 Gilead Sciences shares in Q3 2023, an estimated $1.34M.
Leisure Capital Management first reported a position in Gilead Sciences in Q1 2020 and held it in 8 quarters.
Leisure Capital Management's Gilead Sciences position peaked at $1.44M in Q1 2023.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Leisure Capital Management's 13F filing for Q3 2023, filed 31 Oct 2023.